Takahiko Toyonaga

This study identifies 3-aminobenzoic acid (3-ABA) as a dietary component that enhances intestinal barrier integrity and reduces inflammation in ulcerative colitis models.

The paper finds that increased colonic ACE2 expression in Crohn's disease patients is associated with a higher risk of surgery within 5 years.

This study identifies miR-31 as a marker that stratifies Crohn’s disease patients into two subtypes with distinct clinical outcomes.